Vectorite Biomedical (ROCO:4170) FCF Margin % : 11.15% (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Vectorite Biomedical FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Vectorite Biomedical's Free Cash Flow for the six months ended in Dec. 2023 was NT$3.33 Mil. Vectorite Biomedical's Revenue for the six months ended in Dec. 2023 was NT$29.87 Mil. Therefore, Vectorite Biomedical's FCF Margin % for the quarter that ended in Dec. 2023 was 11.15%.

As of today, Vectorite Biomedical's current FCF Yield % is -0.50%.

The historical rank and industry rank for Vectorite Biomedical's FCF Margin % or its related term are showing as below:

ROCO:4170' s FCF Margin % Range Over the Past 10 Years
Min: -724.97 Med: -99.43 Max: 32.19
Current: -6.19

During the past 12 years, the highest FCF Margin % of Vectorite Biomedical was 32.19%. The lowest was -724.97%. And the median was -99.43%.

ROCO:4170's FCF Margin % is ranked better than
75.31% of 1045 companies
in the Biotechnology industry
Industry Median: -139.31 vs ROCO:4170: -6.19

Vectorite Biomedical FCF Margin % Historical Data

The historical data trend for Vectorite Biomedical's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectorite Biomedical FCF Margin % Chart

Vectorite Biomedical Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-61.53

-252.53

-234.93

32.19

-6.19

Vectorite Biomedical Semi-Annual Data
	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-	-90.56	105.20	-26.12	11.15

Competitive Comparison of Vectorite Biomedical's FCF Margin %

For the Biotechnology subindustry, Vectorite Biomedical's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vectorite Biomedical's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vectorite Biomedical's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Vectorite Biomedical's FCF Margin % falls into.

Vectorite Biomedical FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Vectorite Biomedical's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-3.457	/	55.853
	=	-6.19 %

Vectorite Biomedical's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	3.329	/	29.869
	=	11.15 %

Vectorite Biomedical FCF Margin % Related Terms

Thank you for viewing the detailed overview of Vectorite Biomedical's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Vectorite Biomedical (ROCO:4170) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectorite Biomedical Inc (ROCO:4170) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Xintai 5th Road, 6th Floor, Number 97, Section 1, Yuzhi District, New Taipei City, Taipei, TWN, 22175

Website

http://www.vectorite.com.tw

Vectorite Biomedical Inc is a Taiwan-based diagnostic and research company. It prepares studies of adult healthy cells, cell preparation and application.

Vectorite Biomedical (ROCO:4170) Headlines

No Headlines